Viewing data from:

ALCLOMETASONE DIPROPIONATE

ANDA

ALCLOMETASONE DIPROPIONATE | A076587 | SUN PHARMA CANADA INC

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Alclometasone Dipropionate (2023)

Total Spending

$2.4M

Total Claims

51,874

Beneficiaries

35,440

Avg Cost/Unit

$1.07

Spending Trend

$4.3M(2019)→$3.3M(2020)→$3.1M(2021)→$3.0M(2022)→$2.4M(2023)

YoY Change:-8.2%

5yr CAGR:-3.2%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

API Supply Chain2 active DMFs

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

TAPI NL BVALCLOMETASONE DIPROPIONATE

DMF 146922000

CURIA SPAIN SAUALCLOMETASONE DIPROPIONATE

DMF 168712003

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 0.05%

0 patents0 exclusivities▴

CREAM;TOPICAL | Approved: Sep 15, 2005

No patent or exclusivity listings for this strength.